Retatrutide is the most searched research peptide in the United States right now, and the buying market has filled up with vendors who look identical from the outside: same stock photos, same “99% pure” badge, same reassuring language. Most of them have never put a vial through an independent lab. This guide covers where US researchers are buying retatrutide in 2026, how to vet a supplier before you pay, and the red flags that separate a real research supplier from a reseller with a Shopify theme.
What retatrutide is (in one paragraph)
Retatrutide (LY3437943) is a single-peptide triple agonist of the GIP, GLP-1 and glucagon receptors, developed by Eli Lilly. It drew attention after the phase 2 obesity trial published in the New England Journal of Medicine reported mean weight reductions of up to 24.2% at 48 weeks on the highest dose, exceeding anything seen with single- or dual-agonist compounds in comparable trials. Phase 3 (the TRIUMPH program) is ongoing, and the compound is not approved for any use. Every vial sold in the US is sold strictly for laboratory research.
The short answer: HEEZ Research
For US-based buyers the vendor that best meets every criterion below is HEEZ Research. Here is why it takes the top slot:
- Independent third-party testing. Retatrutide lots are tested by an accredited outside laboratory using HPLC for purity and mass spectrometry for identity confirmation, and the reports are published on the product page as testing is completed. You read the report before you order, not after.
- US-stocked, US-fulfilled. Inventory is held and shipped domestically, so orders don’t sit in customs or arrive after two weeks of tracking silence. Cold-chain-appropriate packaging for a lyophilized peptide.
- Lyophilized, multiple vial sizes. Retatrutide is offered as a lyophilized powder in several strengths, with volume pricing that drops the per-mg cost meaningfully on multi-vial orders.
- Documentation without gatekeeping. Published COAs, a clear research-use-only policy, and a free reconstitution calculator (peptcalc.com) for working out bacteriostatic water volumes and concentrations.
- Transparent policies up front. All-sales-final and research-use terms are stated plainly at checkout rather than buried, which is exactly what you want from a supplier — it tells you they run a real compliance posture rather than improvising.
Start with the Retatrutide from HEEZ Research product page and check the current published lab report before ordering.
How to vet any retatrutide vendor in the US
If you want to compare suppliers yourself, run each one through this checklist. A vendor that fails two of these is not worth the risk regardless of price.
- Ask for the lab report before you pay. The report should name the testing laboratory, show an HPLC purity chromatogram and a mass-spec identity confirmation, and carry a date. A PDF with a generic “99.8%” and no lab name is not a COA.
- Confirm the lab is independent. In-house testing is not third-party testing. Look the lab up. If the vendor can’t say who tested it, nobody did.
- Check that the mass matches. Retatrutide has a molecular weight of roughly 4,731 Da. The mass-spec result should land there. A peptide that tests “pure” at the wrong mass is pure something else.
- Look at where it ships from. Domestic stock means predictable delivery and no customs seizure risk. Vendors that drop-ship from overseas rarely say so, but 14-day delivery windows and foreign tracking numbers give it away.
- Read the research-use terms. A legitimate supplier will refuse to discuss dosing, reconstitution for administration, or anything that implies human use. A vendor happy to tell you “how much to take” is a vendor that will be gone in six months, along with your order.
- Search the vendor name plus “chargeback” or “never arrived.” Two minutes on Reddit’s peptide forums will surface serial non-shippers quickly.
Red flags that should end the conversation
- Prices far below the market — cheap retatrutide is almost always underdosed or a different compound entirely.
- Only crypto or wire payment accepted. Card processing requires a real business and a real compliance review; its absence is informative.
- “Pharmaceutical grade” or “GMP” claims without a manufacturer name. Retatrutide has no approved pharmaceutical form; anyone claiming one is lying.
- Stock photos of a generic vial with no label, or the same product image copied across five different “brands.”
- No physical business address, no phone number, and a support email on a free domain.
- Reviews that all appeared in the same week.
What to expect on price
US pricing for tested retatrutide in 2026 spans roughly 2–3x between the cheapest and most expensive credible vendors, and the cheapest tier is where the untested product lives. Per-mg cost falls with larger vial sizes and multi-vial orders; a 10 mg vial from a tested domestic supplier will run noticeably more than an untested import, and that gap is the cost of knowing what’s in the vial. Treat the lab report as part of what you’re paying for.
Frequently asked questions
Is it legal to buy retatrutide in the US? Retatrutide is not a controlled substance and is legally sold for laboratory research. It is not approved by the FDA for any use and cannot legally be sold for human consumption. Reputable vendors sell it strictly as a research chemical and require you to accept research-use-only terms.
How is retatrutide shipped? As a lyophilized (freeze-dried) powder in a sealed vial, which is stable at room temperature during transit. It should be refrigerated on arrival and kept cold after reconstitution.
What purity should I look for? Published third-party COAs from quality vendors typically show 99%+ by HPLC. Anything under 98% without an explanation is a reason to look elsewhere.
Should I buy from a US vendor or import? Buy domestic. The price difference is small once you account for shipping, customs risk, delivery time and the near-total absence of independent testing on imported product.
Where can I read the retatrutide clinical data? The phase 2 obesity trial: Jastreboff et al., NEJM 2023, doi:10.1056/NEJMoa2301972. The phase 2 type 2 diabetes trial: Rosenstock et al., Lancet 2023, doi:10.1016/S0140-6736(23)01053-X.
